Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2005
08/11/2005WO2005072364A2 A modified baculovirus expression system for production of pseudotyped raav vector
08/11/2005WO2005072290A2 Methods of treating, reducing, or preventing autoimmune conditions
08/11/2005WO2005072272A2 Compositions and methods for generating short double-stranded rna using mutated rnase iii
08/11/2005WO2005072270A2 Methods and compositons for treating cancer
08/11/2005WO2005072262A2 Methods and compositions for evolving microbial hydrogen production
08/11/2005WO2005072254A2 Modulation of sulfate permease for photosynthetic hydrogen production
08/11/2005WO2005072223A2 Engineered proteins, and methods of making and using
08/11/2005WO2005072186A2 Glyphosate tolerant plants and methods of making and using the same
08/11/2005WO2005072133A2 Nucleic acid detection
08/11/2005WO2005072129A2 Production of host cells containing mutiple integrating vectors by serial transduction
08/11/2005WO2005072112A2 Methods for producing and identifying multispecific antibodies
08/11/2005WO2005072100A2 Generation of plants with altered oil content
08/11/2005WO2005072092A2 Systems for tightly regulated gene expression
08/11/2005WO2005072088A2 Immunotherapy compositions, method of making and method of use thereof
08/11/2005WO2005072086A2 Optimized bacterial host strains of methylomonas sp.16a
08/11/2005WO2005072057A2 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
08/11/2005WO2005054442A3 Yeast strains resistant to purine base analogues, process for the production thereof, yeast extracts obtainable from said yeast strains and use of said yeast strains or yeast extracts in food, drink and beverabes
08/11/2005WO2005047513A3 Glycin decarboxylase complex as a herbicidal target
08/11/2005WO2005046579A3 Defined dose therapeutic phage
08/11/2005WO2005045034A3 RNA INTERFERENCE MEDIATED TREATMENT OF PARKINSON DISEASE USING SHORT INTERERING NUCLEIC ACID (siNA)
08/11/2005WO2005042752A9 Symbiotic mutant of pea (pisum sativum l.)
08/11/2005WO2005040389A3 Compositions with chitinase activity
08/11/2005WO2005040344A3 Generation of stabilized proteins by combinatorial consensus mutagenesis
08/11/2005WO2005033287A3 Methods for identifying a biosynthetic pathway gene product
08/11/2005WO2005030965A3 Expansin polypeptides
08/11/2005WO2005019457A3 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY
08/11/2005WO2005010145A3 Method and compositions for detection and enumeration of genetic variations
08/11/2005WO2005001099A3 Protein expression system
08/11/2005WO2005000899A3 Modified binding molecules comprising connecting peptides
08/11/2005WO2004096016A3 Modulation of glucagon receptor expression
08/11/2005WO2004083394A3 Human g protein-coupled receptors and modulators thereof for the treatment of inflammatory disorders
08/11/2005WO2004043407A3 Methods and products for treating staphylococcal infections
08/11/2005WO2004042063A8 Pharmaceutical composition for preparing a medicine for treating and/or preventing a pathology related to an obsessive behaviour or obesity
08/11/2005WO2004033636A3 Protein modification and maintenance molecules
08/11/2005WO2004012683A3 Novel druggable regions in set domain proteins and methods of using the same
08/11/2005WO2003088899A3 Methods for the production of chimeric adeno-associated virus (aav) vectors, compositions of chimeric aav vectors, and methods of use thereof
08/11/2005WO2003087377A9 Insecticide proteins from photorabdus luminescens
08/11/2005WO2003077836A3 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
08/11/2005WO2003076634A3 Transcriptional regulation of ptp-1b
08/11/2005WO2003076592A3 Novel method for delivery and intracellular synthesis of sirna molecules
08/11/2005WO2003072733A3 Modified bace
08/11/2005WO2003054148A3 Zinc finger-based drug-dependent gene regulation system
08/11/2005WO2003035858A3 Bacterial polypeptides involved in nucleic acid processing
08/11/2005WO2003023000A3 Linear dna fragments for gene expression
08/11/2005US20050177904 Inbred corn line D603
08/11/2005US20050177903 Regulation of translation of heterologously expressed genes
08/11/2005US20050177902 Methods of producing specialty grain to segment markets
08/11/2005US20050177901 Expression vector comprising nucleotide sequences coding proteins associated with carbohydrate metabolism, degradation and biosynthesis for use in enhancement of nutrient quality of crop plants
08/11/2005US20050177900 Impartment of virus-resistance with the use of plant protein binding to plant virus transport protein
08/11/2005US20050177899 Non-transgenic herbicide resistant plants
08/11/2005US20050177898 Maize metallothionein 2 promoter and methods of use
08/11/2005US20050177897 Isolated nucleic acid molecule of a nucleotide sequence for promoters that initiate transcription
08/11/2005US20050177895 Inbred corn line KW4U110
08/11/2005US20050177894 Inbred corn line D501
08/11/2005US20050177893 Transcription factors and methods for introduction of value-added seed traits and stress tolerance
08/11/2005US20050177892 Maize Rar1-interactor polynucleotides and methods of use
08/11/2005US20050177891 Novel plant glucosidase I and use thereof for producing recombinant proteins with modified glycosylation
08/11/2005US20050177890 Transposon being functional in mammals
08/11/2005US20050177889 Generating diploid transgenic fish using nuclear transplantation; animal models
08/11/2005US20050177887 Cells homozygous for pituitary tumor transforming gene (PTTG) mutation for use as models in diagnosis, prevention and treatment of blood, pancreatic and fertility disorders
08/11/2005US20050177885 CCN1 transgenic animals
08/11/2005US20050177883 Systems of transferring embryos and managing recipients
08/11/2005US20050177882 Method and system for fusion and activation following nuclear transfer in reconstructed embryos
08/11/2005US20050177881 Using presence of allelic mutations in lysosomal acid lipase (LIPA) and cholesterol 25-hydroxylase (CH25H) as diagnostic indicator of nervous system disorders
08/11/2005US20050177880 Nucleic acid isolated from the 5' nontranslated region (5'NTR) end of the human FGF-1 gene having IRES activity
08/11/2005US20050177879 Using nuclear transplantation to generate animal which express human growth hormone in mammary glands; bioreactors
08/11/2005US20050177878 Process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby
08/11/2005US20050177877 Process for producing physiologically active protein using genetically modified silkworm
08/11/2005US20050177876 Fcyriia transgenic animal model for autoimmune disease
08/11/2005US20050176948 Libraries; locked nucleic acids; peptide nucleic acids
08/11/2005US20050176946 Constitutive promoter from Arabidopsis
08/11/2005US20050176944 Intracellular signaling polypeptide for identifying modulator for prevention and treatment cell proliferative, endocrine, autoimmune/inflammatory, neurological, gastrointestinal, reproductive, developmental, and vesicle trafficking disorders
08/11/2005US20050176943 Nucleotide sequences coding sperm maturation polypeptides for identifying modulators for treatment and prevention of male sterility
08/11/2005US20050176940 Aptamers and antiaptamers
08/11/2005US20050176933 Nucleotide sequences coding hepatocyte specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; immunotherapy; antitumor agents
08/11/2005US20050176931 Eotaxin : eosinophil chemotactic cytokine
08/11/2005US20050176930 Nucleotide sequences coding tumor associated antigen for use in diagnosis, prevention and treatment of cell proliferative disorders; mimetics; antitumor agents
08/11/2005US20050176929 Hiv-1 subtype isolate regulatory/accessory genes, and modifications and derivatives thereof
08/11/2005US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis
08/11/2005US20050176740 Synergistic for cancer characterized by ras oncogene overexpression; N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine
08/11/2005US20050176672 Use of cationic lipids to generate anti-tumor immunity
08/11/2005US20050176671 Drug screening; competitive binding; antitumor agents, antiproliferative agents, as promoter providing neuronal cell growth, wound healing, and cerebral injury healing; receptor binding assay, gene expression
08/11/2005US20050176670 Recombinant DNA for gene suppression
08/11/2005US20050176669 Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence
08/11/2005US20050176668 VPS35-based assays and methods for treating Alzheimer's disease
08/11/2005US20050176667 Compositions and methods for inhibiting expression of anti-apoptotic genes
08/11/2005US20050176666 Each double stranded siNA sequence is between 18 and 23 nucleotides, directs gene cleavage and also has a complementary antisense region; antiinflammatory agents; respiratory system disorders
08/11/2005US20050176664 RNA interference mediated inhibition of cholinergic muscarinic receptor (CHRM3) gene expression using short interfering nucleic acid (siNA)
08/11/2005US20050176663 RNA interference mediated inhibition of protein tyrosine phosphatase type IVA (PRL3) gene expression using short interfering nucleic acid (siNA)
08/11/2005US20050176661 Antiviral oligonucleotides
08/11/2005US20050176660 Use of specific antisense-based constructs and peptide-specific polyclonal and monoclonal antibodies in leukemia, acute or chronic tissue damages, HIV-related damage of brain or other tissues, skeletal muscle disorders, transplantation rejection; Parkinson's disease; amyotrophic lateral sclerosis
08/11/2005US20050176659 Polypeptide contributing to regulating the metabolism of triglycerides; obesity as well as related disorders such as eating disorder, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, dyslipidemia, osteoarthritis, gallstone, cancers of the reproductive organs
08/11/2005US20050176653 Cultivating a Amycolatopsis orientalis strain under aerobic conditions, chemically modifying the product; antibiotics; anticarcinogenic agent, antiinflammatory agent
08/11/2005US20050176647 Having an alkylation site via a vinyl linker at the end of a pyrrole-imidazole polyamide; inhibits the expression of a specific gene; high anti-cancer activity
08/11/2005US20050176640 poxvirus protein A41L binds to leukocyte common-antigen-related protein; monoclonal antibody; therapeutic agents for an immune and/or inflammatory response; poxvirus
08/11/2005US20050176639 Use of osteopontin for the treatment and/or prevention of neurologic diseases
08/11/2005US20050176634 substitution or the elimination ofcysteine residue (Cys) in the C-terminal portion of the wild type protein polypeptide sequence; prevents multimerisation of monomeric form but does not affect dimerisation; storage stability; treatment of ischemia, scleroderma, skin ulcer, aging, burn, wound; cosmetic
08/11/2005US20050176632 Angiogenesis inhibitors
08/11/2005US20050176629 Telomerase expression repressor proteins and methods of using the same
08/11/2005US20050176150 Using transgenic escherichia as bioreactor in fermenting aminoacylhistidine, leucylamino and iso-aspartyl peptidases
1 ... 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 ... 4023